Midatech Pharma plc
MTPNASDAQHealthcare
$0.29
$-0.06(-18.50%)
Market Cap$1976846
P/E Ratio—
52W High$20.8
52W Low$0.19
Midatech Pharma plc (MTP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MTP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.01B | $0.00B | $0.01B | $0.00B | $0.01B |
| Gross Profit | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) |
| Gross Margin %(computed) | — | -967.45% | -631.19% | -705.19% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.00B | $0.01B | $0.00B | $0.02B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.02B |
| Operating Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) |
| Net Margin %(computed) | — | — | — | -944.64% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-11.57 | $-2.29 | $-49.43 | $-35.25 | $-143.27 |
| Wtd Avg Shares | 6.20B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) |
| EBITDA Margin %(computed) | — | — | — | -979.07% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · GBP · B
Explore more Midatech Pharma plc data
About Midatech Pharma plc (MTP) Income Statement
Midatech Pharma plc (MTP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, MTP reported revenue of $0.00B, gross profit of ($0.01B) (gross margin —), and net income of ($0.01B) — a net profit margin of —.
Frequently asked questions
MTP · 4 questionsMidatech Pharma plc (MTP) reported revenue of $0.00B for 2024, down 100.0% year-over-year.
MTP revenueMTP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09